Abstract
RNA may be released from vascular cells including endothelial cells in the event of injury and in vascular disease. Extracellular RNAs have been recognized as novel procoagulant and permeability-increasing factors. Extracellular RNA may function as inflammatory host alarm signals that serve to amplify the defense mechanism, but it may provide important links to thrombus formation. Extracellular RNA is degraded by RNase. We propose that RNase and its inhibitor RNase inhibitor (RI) act as modulators of homeostasis in the vasculature to control the functions of extracellular RNA. We aimed to investigate the expression and localization of RNase 1 and RI in cells that contact blood, such as platelets, mononuclear cells, polymorphonuclear cells, and red blood cells. RNase 1 and RI expression and localization in blood cells were compared with those in the human umbilical vein endothelial cell line, EAhy926. Additionally, we further investigated the effect of thrombin on the expression of RNase 1 and RI in platelets. We used an RNase activity assay, reverse transcription-polymerase chain reaction, western blot, immunocytochemistry, transmission electron microscopy, and immunoelectron microscopy (pre- and post-embedding methods). RNase activity in the supernatant from EAhy926 cells was 50 times than in blood cells (after 60 min). RNase 1 mRNA and protein expression in EAhy926 cells was highest among the cells examined. However, RI mRNA and protein expression was similar in most cell types examined. Furthermore, we observed that RNase 1 and von Willebrand factor were partially colocalized in EAhy926 cells and platelets. In conclusion, we propose that high RNase activity is ordinarily released from endothelial cells to support anticoagulation in the vasculature. On the other hand, platelets and leukocytes within thrombi at sites of vascular injury show very low RNase activity, which may support hemostatic thrombus formation. However, activated platelets and leukocytes may accelerate pathologic thrombus formation.
Highlights
RNA may be released from vascular cells including endothelial cells in the event of injury and in vascular disease
We propose that RNase and its inhibitor RNase inhibitor (RI) act as modulators of homeostasis in the vasculature to control the functions of extracellular RNA
We found that RNase activity in blood cells was low compared with that in EAhy926 cells
Summary
RNA may be released from vascular cells including endothelial cells in the event of injury and in vascular disease. Extracellular RNAs have been recognized as novel procoagulant and permeability-increasing factors [1,2,3,4]. Not all RNA species have clotting function. Long RNAs, those composed of over 100 nucleotides, can serve as templates for the contact phase of blood coagulation [1, 2]. Hairpin-forming RNAs appear to be more potent at activating blood coagulation [5]. Polyphosphate has been identified as a contact phase activation factor [6, 7]. Polyphosphate molecules composed of over 60 phosphate residues can act as potent procoagulant agents [8]. Contact activation is the predominant prothrombotic effect of microbial long-chain polyphosphates (several hundred monomers), while physiological intermediate-chain polyphosphates (60–100 monomers) cannot induce contact activation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have